Industry Seeks to Minimize Overexposure, Supports Responsible Tanning
NEW YORK (Oct. 15, 2013) – The professional indoor tanning salon community supports initial reports of New York City Mayor Michael Bloomberg’s initiative to increase compliance with New York City rules for professional tanning facilities.
The American Suntanning Association – the nation’s largest association of professional suntanning facilities – reached out to the Mayor’s office today to support his initiative. The tanning community has long been a proponent of enforcing existing laws and is already executing many of the precautions laid out in press accounts of Mayor Bloomberg’s proposal. The salon community will support any city-wide effort to increase compliance with the standards already in place in professional salons.
“Our industry has always supported efforts to reduce overexposure and risk. Like many things, UV exposure is all about moderation and responsibility. Salon owners should be held accountable for following regulations and not allow a few bad actors to sully the industry,” American Suntanning Association Advisor Joseph Levy said.
“We agree with the Mayor that there should be additional regulation to crack down on anyone acting irresponsibly and American Suntanning Association salons are happy to work with the Mayor on this initiative,” Levy said.
According to initial media reports, the Mayor’s plan includes the following, all of which the ASA supports:
• Require the health department to inspect tanning salons.
• Crack down on unlicensed operators.
• Require operators of UV equipment to undergo training. Enforce the law that bars
adolescents under 17 from frequenting tanning shops.
• Launch a public education campaign about the dangers of too much UV exposure.
For more information about ASA visit www.TanResponsibly.org.
October 9, 2013.
Today the Indoor Tanning Association (ITA) and the American Suntanning Association (ASA) announced a cooperative strategy for 2014 and beyond to promote and defend our industry.
The ITA, founded in 1999 is the industry’s oldest trade association and has historically represented the interests of every indoor tanning market segment including tanning salons. The ASA was organized one year ago as a salon-only organization. Over the past year, there has been some redundancy with both groups working independently on issues that impacted all segments of the industry. This plan is designed to optimize and increase industry resources particularly in efforts related to Washington, D.C.
Under the new arrangement, the ITA will continue to represent the tanning industry but will focus its resources primarily on manufacturer related tanning equipment and tanning products issues. The ITA will also focus on Federal policy, Federal regulations and the industry political action committee fund.
The ASA will continue to manage all state lobbying, scientific relationships, and media and PR efforts on behalf of its members in the tanning salon market segment. The ASA will also continue to handle federal lobbying issues affecting tanning salons.
The two groups will share information and work closely on all issues that impact our industry. ITA Executive Director John Overstreet will work closely with ASA President Bart Bonn to implement this strategy.
The two organizations are pleased to announce this plan. There is broad agreement that cooperation is a key element for increasing our capabilities to protect and then grow our industry. We encourage everyone in our industry to step up and get involved.
ASA Members and Supporters,
The U.S. Centers for Disease Control is collecting public input until Sept. 4 for a report intended to convince the U.S. Surgeon General to release a public statement on UV and skin cancer. It seems apparent this is part of the American Academy of Dermatology Association’s lobbying initiative to get surgeon general’s warnings put on sunbeds to continue their “sun scare” campaign to liken UV to smoking.
To help get CDC to meet with ASA scientists, we’d like you to send a united message that CDC needs to work with us before they proceed with any kind of report. ASA is submitting a scientific response to this. For our industry to succeed in this campaign, it is critical that we send as many letters as possible echoing this concern.
So we’ve made it easy for you to submit a response electronically.
1. Click here to go to the comment submission page
2. Type in your personal response or copy and paste the text below into the comment box
3. Fill out your information
4. Click “Continue” to review your submission
5. Check “I read and understand the statement above” and then click “Submit Comment”
Dear CDC -
A very brief 30-day public comment period (Aug. 5, 2013-Sept. 4, 2013) for a report which will have major public policy ramifications is incapable of producing material worthy of this broad-reaching topic for the following reasons:
(1) The main premise of your Notice — “preventing skin cancer through reduction of UV exposure” —and your broad statement that “A majority of skin cancers are caused by exposure to ultraviolet (UV) radiation from the sun or from indoor tanning devices” is very limited. It leads one to infer that you are already predisposed to a conclusion that most science suggests is not as black-and-white as your Notice infers and which is actually debated in the scientific community.
Melanoma skin cancer is more common in indoor workers than outdoor workers, who receive many times more UV exposure, and is most common on parts of the body that do not receive regular UV exposure. What’s more, melanoma mortality and incidence are increasing fastest in older men — the group least-likely to be addressed by this Notice’s stated areas of focus.
Further, your statement that “An estimated 3.7 million cases of basal and squamous cell carcinomas …are diagnosed in the U.S. annually” shows a lack of understanding of this issue. That figure refers to dermatology’s estimated number of procedures — not cases. One case is often represented by dozens of procedures, and there is no actual incidence registry of either of these cancers in the United States nor is there any government number showing an actual increase in these diseases.
(2) This document calls for policy about UV exposure to be based solely on the basis that any UV exposure leads to skin cancer (a conclusion that, again, is debated — a debate which is not reflected in your Notice) at a time when science is clearly starting to understand the broad-reaching benefits of regular UV exposure — benefits that are both vitamin D-related and which are now understood to be solely related to UV exposure itself. Acknowledgement of these fields of research is fully lacking in your Notice, nor is there any indication you have involved any of these disciplines in your process.
(3) Your announcement was buried in the Federal Register at the end of summer during a period when very few of the affected scientific fields or stakeholders would see this document, let alone have sufficient time in 30 days to respond.
This topic deserves a higher-level conversation before a CDC report or a Surgeon General recommendation about UV exposure should be drawn. I would like to join many Americans who insist that you conduct a more thorough, public and inclusive panel of experts and public participants to examine the broad-reaching affects of UV policy fully before proceeding. As it is, your Notice suggests your public understanding of this issue is based solely on the dermatology industry’s lobbying points.
ASA Members and Supporters,
It is critical that you take action today to stop the regulation changes proposed by the FDA. These changes would not only impact the manufacturers of suntanning equipment, but also the salons that currently own and purchase suntanning equipment. For our industry to succeed in this campaign, it is crucial that we send as many letters as possible.
We’ve made it easy for you to submit a response electronically.
1. Click here to go to the regulation proposal’s page
2. Once there, click on “Comment Now!”
3. Fill out your information (choose “Device Industry – C0012″ as the category)
4. Copy and paste this text into the comment box (feel free to customize):
As a sunbed salon owner, my business will be harmed by the unintended consequences of FDA’s proposed order to re-classify tanning equipment as Class 2 medical devices and amend warning labels to include a statement about minors.
(1) The proposed order provides that products already in the marketplace must cease being used if the manufacturer does not submit a 510(k) within one year of the order’s effective date. This is simply not possible, as many equipment manufacturers are no longer in business. (2) It will be cost-prohibitive for manufacturers still in business to retroactively file a 510(k), and many won’t. That will make it mandatory for sunbed salons to replace much or all of their equipment at elevated prices, forcing many to close.
Closing salons is the written lobbying goal of the AAD, which FDA partnered with to announce this order in its May 6 press conference. FDA’s 2010 Plastic Surgery Advisory Panel included 9 AAD members (6 dermatologists and 3 plastic surgeons) — a conflict of interest since dermatology stands to gain financially from measures that close or restrict tanning salons. Dermatology condones its own usage of sunbeds competitively to tanning salons and has lobbied to expand that “safe” service. No panel member declared that conflict, despite being asked.
That conflict of interest appears to have tainted analysis of the data supplied to FDA. Data in the WHO IARC report implicate dermatology sunbeds (96%) as the major source of risk increase for under-35 users, but showed that commercial salons did not increase risk significantly (6%).
Neither the science behind nor the effects of this order have been properly considered. FDA should revisit this issue in constructive cooperation with the sunbed market and qualified independent epidemiologists – using the working group stakeholder meeting format it convened Feb. 7-8, 2002 — before proceeding with any rule revision.
5. Click “Submit”
All comments must be submitted by August 1! Please take a couple minutes to submit your comments today.
Thank you for your help!
American Suntanning Association
The U.S. Food and Drug Administration on Monday announced a proposal to change pre-market manufacturing standards for sunbeds, including a suggestion that sunbed labels add a statement urging young people not to use sunbeds.
FDA’s proposal comes three years after a non-binding FDA advisory panel urged the agency to seek changes, including reclassifying sunlamp products as Class II medical device instead of a Class I device. The reclassification would require manufacturers to change the way they introduce new sunlamp products — a change that, by itself, does not change the end-consumer experience with sunbeds.
“If the order is finalized, manufacturers would have to submit a pre-market notification (510(k)) to the FDA for these devices, which are currently exempt from any pre-market review,” the FDA said in a statement. “Manufacturers would have to show that their products have met certain performance testing requirements, address certain product design characteristics and provide comprehensive labeling that presents consumers with clear information on the risks of use. The order proposes to include a contraindication against use on people under 18 years old, and the labeling would have to include a warning that frequent users of sunlamp products should be regularly screened for skin cancer.”
Sunbeds already include clear warning labels — labels the sunbed market worked with FDA to create. In a 2002 meeting with FDA, the sunbed community and FDA constructively agreed on changes to that warning label spurred by a 1999 request that sunbed rules be reviewed.
FDA has not involved the American Suntanning Association in development of the current proposal.
“The professional sunbed community has not had any input in this preliminary proposal thus far. We remain dedicated to sunburn prevention and look forward to working with the FDA to improve consumer protection and to assure that all information regarding indoor tanning is in accordance with the science,” the ASA said in a statement released to the media 30 minutes after Monday’s press conference.
The ASA will work with other industry groups to participate in the process with the FDA constructively.
The FDA will take comments on the proposed order for 90 days.
To read the FDA’s press release click here.
To read the FDA’s proposal, click here.
To read current FDA regulations, click here.